MADRIGAL PHARMACEUTICALS, INC. financial data

Symbol
MDGL on Nasdaq
Location
West Conshohocken, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 473% % -34%
Quick Ratio 24% % 674%
Debt-to-equity 58% % 68%
Return On Equity -42% % 42%
Return On Assets -26% % 51%
Operating Margin -42% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 22,711,420 shares 4.1%
Common Stock, Shares, Outstanding 22,704,303 shares 4.1%
Entity Public Float $5,100,000,000 USD 61%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 22,482,502 shares 3.4%
Weighted Average Number of Shares Outstanding, Diluted 22,482,502 shares 3.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $137,250,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $740,640,000 USD 362%
Operating Income (Loss) $307,485,000 USD 44%
Net Income (Loss) Attributable to Parent $289,125,000 USD 44%
Earnings Per Share, Basic -12 USD/shares 49%
Earnings Per Share, Diluted -12 USD/shares 49%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $295,694,000 USD 27%
Cash, Cash Equivalents, and Short-term Investments $1,114,749,000 USD 11%
Accounts Receivable, after Allowance for Credit Loss, Current $113,285,000 USD 272%
Inventory, Net $69,317,000 USD 695%
Assets, Current $1,346,680,000 USD 27%
Property, Plant and Equipment, Net $2,913,000 USD 28%
Operating Lease, Right-of-Use Asset $5,387,000 USD 114%
Assets $1,362,457,000 USD 27%
Accounts Payable, Current $44,941,000 USD -2.2%
Employee-related Liabilities, Current $51,108,000 USD 72%
Accrued Liabilities, Current $345,382,000 USD 164%
Liabilities, Current $391,406,000 USD 120%
Operating Lease, Liability, Noncurrent $5,566,000 USD 373%
Liabilities $736,725,000 USD 149%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,068,000 USD -16%
Retained Earnings (Accumulated Deficit) $2,031,891,000 USD -17%
Stockholders' Equity Attributable to Parent $625,732,000 USD -19%
Liabilities and Equity $1,362,457,000 USD 27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $88,891,000 USD 40%
Net Cash Provided by (Used in) Financing Activities $8,640,000 USD -98%
Net Cash Provided by (Used in) Investing Activities $163,878,000 USD 67%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 22,704,303 shares 4.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $83,627,000 USD -84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $300,694,000 USD 27%
Deferred Tax Assets, Valuation Allowance $508,811,000 USD 33%
Deferred Tax Assets, Gross $509,028,000 USD 33%
Operating Lease, Liability $2,001,000 USD 17%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $289,328,000 USD 44%
Lessee, Operating Lease, Liability, to be Paid $2,222,000 USD 19%
Operating Lease, Liability, Current $1,083,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,072,000 USD 124%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,150,000 USD 23%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $221,000 USD 49%
Deferred Tax Assets, Operating Loss Carryforwards $214,427,000 USD 76%
Preferred Stock, Shares Issued 2,369,797 shares 0%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Preferred Stock, Shares Outstanding 2,369,797 shares 0%
Depreciation, Depletion and Amortization $379,000 USD 126%
Deferred Tax Assets, Net of Valuation Allowance $217,000 USD 85%
Share-based Payment Arrangement, Expense $90,018,000 USD 17%
Interest Expense $3,297,000 USD -14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%